New Delhi: The Supreme Court Friday asked private hospitals whether they are ready to provide treatment to COVID-19 infected patients at the charges prescribed under the government's Ayushman Bharat Scheme.
The 'Ayushman Bharat Pradhan Mantri Jan Arogya Yojana' is aimed at providing health cover to poor and vulnerable persons in the country.
A bench headed by Chief Justice S A Bobde said the apex court is not asking all the private hospitals to treat certain number of COVID-19 patients for free.
The bench, also comprising Justices A S Bopanna and Hrishikesh Roy, said it is asking only those private hospitals which have been given land at concessional rates by the government to treat certain number of coronavirus infected patients for free.
"I just want to know if hospitals are ready to charge at Ayushman rates?," the CJI observed during the hearing which was conducted through video-conferencing.
Solicitor General Tushar Mehta, appearing for the Centre, told the bench that government is doing its best for the lowest strata of the society and people who cannot afford treatment are covered under the Ayushman Bharat scheme.
The top court, which posted the matter two weeks from now, was hearing a plea seeking a direction for regulating the cost of treatment of COVID-19 at private hospitals across the country.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
New Delhi (PTI): India and New Zealand on Monday inked a free trade agreement, aimed at boosting two-way commerce and investments.
The pact was signed by Commerce and Industry Minister Piyush Goyal and visiting New Zealand's Trade and Investment Minister Todd McClay.
The FTA provides duty-free access for 100 per cent of India's exports to New Zealand, covering all tariff lines or produce categories, and is expected to significantly boost MSMEs and employment by enhancing competitiveness in labour-intensive sectors such as textiles, apparel, leather, footwear, gems and jewellery, engineering goods, and processed foods.
Earlier, New Zealand maintained peak tariffs of up to 10 per cent on key Indian exports, including ceramics, carpets, automobiles, and auto components.
With zero-duty market access from entry into force as New Zealand's other trade partners, Indian products will be fully competitive in that country, enjoying a level playing field.
ALSO READ: Cal HC urges EC to dispose of TMC complaint over police observer's meeting with BJP nominee
Significantly, India also secured duty-free inputs for its manufacturing sector, including wooden logs, coking coal, and waste and scraps of metals, lowering production costs and enhancing the global competitiveness of the Indian industry.
On the other hand, India has offered tariff liberalisation on 70.03 per cent of tariff lines covering 95 per cent of bilateral trade value, while keeping 29.97 per cent of tariff lines excluded to protect India's sensitive sectors.
The products that are kept in exclusion are mainly -- dairy (milk, cream, whey, yoghurt, cheese etc.), animal products (other than sheep meat), agricultural products (onions, chana, peas, corn, almonds), sugar, artificial honey, animal, vegetable or microbial fats and oils, arms and ammunition, gems and jewellery, copper and articles thereof (cathodes, cartridges, rods, bars, coils), aluminium and articles thereof (ingots, billets, wire bars) among others.
On 30 per cent of tariff lines of New Zealand, India will provide duty elimination on goods such as wood, wool, sheep meat, and leather-raw hides.
Similarly, 35.60 per cent of tariff lines are subject to phased elimination over 3, 5, 7, and 10 years, including petroleum oil, malt extract, vegetable oils, selected electrical and mechanical machinery, and peptones.
New Zealand products which enjoy tariff reductions include wine, pharmaceutical drugs, polymers, aluminum, iron and steel articles, and goods that only 0.06 per cent fall under tariff rate quotas, including Manuka honey, apples, kiwi fruit, and albumins, including milk albumin.
The FTA also includes a commitment to facilitate USD 20 billion in investment into India.
A rebalancing clause is incorporated into the Agreement to provide a framework for addressing any shortfall in investment delivery, thereby ensuring robust and tangible economic outcomes.
Total bilateral trade in goods and services reached USD 2.4 billion in 2024.
